Is Semaglutide safe for weight loss in breast cancer?

Question

Hello doctor,

I have been having difficulty managing my weight and metabolic syndrome despite consistent diet and exercise. I am now considering compounded Semaglutide for more tailored dosing. However, I was diagnosed with malignant breast carcinoma three months ago and am preparing to begin chemotherapy and radiation.

I am concerned about potential interactions between Semaglutide and my cancer treatments. Could Semaglutide affect the absorption or metabolism of chemotherapy agents, or interfere with their effectiveness? Are there safety concerns with using a GLP-1 receptor agonist while undergoing active cancer treatment? Should the timing of Semaglutide doses be adjusted around chemotherapy sessions to reduce any risks?

What monitoring or lab tests would be advisable before and during Semaglutide use in this context? I am also concerned that it might worsen gastrointestinal side effects or lead to dehydration, which could impact my nutritional status during treatment. If Semaglutide is not advisable, what alternative, cancer-safe weight management options would you suggest? Would it be appropriate to coordinate care with both my oncologist and an endocrinologist? Please help.

Thank you.

Answer 1

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

Semaglutide has been studied for its potential to slow the growth and progression of breast cancer, a type of cancer that begins in the cells of the breast. It occurs when abnormal breast cells grow and divide uncontrollably, forming a tumor that can sometimes spread (metastasize) to other parts of the body. It is possible to support the body’s antitumor immune response. While gastrointestinal side effects are common with Semaglutide and similar weight loss medications, they generally do not interfere significantly with cancer treatments. If you have been undergoing chemotherapy for a couple of months and are tolerating it well, it may be appropriate to consider these medications under close supervision.

Current evidence suggests that the GLP-1 receptor (glucagon-like peptide-1 receptor) is a protein found on the surface of certain cells in your body, especially in the pancreas, brain, and digestive tract. Agonists like Semaglutide do not adversely affect breast cancer outcomes, which offers some reassurance to both patients and clinicians.

In terms of nutrition, oncology dietitians typically recommend a plant-based diet rich in fruits, vegetables, whole grains, and legumes. These foods are nutrient-dense and lower in calories, which can support healthy weight management during cancer treatment.

For the safest and most effective approach, I strongly recommend consulting both your oncologist (cancer specialist) and an endocrinologist (endocrine specialist) to evaluate your treatment options.

I hope this helps.

Thank you.